Patent foramen ovale and cryptogenic stroke: A matter of age?

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 5, 2009, Pages 505-514

  Handke, Michael ^a   Harloff, Andreas ^b   Bode, Christoph ^b   Geibel, Annette ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Atrial septal aneurysm; Cryptogenic stroke; Elderly; Patent foramen ovale; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

AGE DISTRIBUTION; ANATOMY; ANEURYSM; ANTICOAGULANT THERAPY; BLEEDING; CONTRAST ENHANCEMENT; CRYPTOGENIC STROKE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HEART ATRIUM SEPTUM ANEURYSM; HEART RIGHT LEFT SHUNT; HEART SURGERY; HEART VENTRICLE PRESSURE; HUMAN; IMAGINAL DISC; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SCREENING; SECONDARY PREVENTION; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; ANTICOAGULANTS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FORAMEN OVALE, PATENT; HEART ANEURYSM; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RECURRENCE; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VENOUS THROMBOSIS;

EID: 70449589380     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1234146     Document Type: Review

References (93)

1. Lechat P, Mas J L., Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988 318 (18) 1148-1152
2. Webster M W., Chancellor A M., Smith H J. et al. Patent foramen ovale in young stroke patients. Lancet 1988 2 (8601) 11-12
3. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation 2008 118 (19) 1989-1998
4. Overell J R., Bone I, Lees K R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000 55 (8) 1172-1179
5. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007 357 (22) 2262-2268
6. Force M, Massabuau P, Larrue V. Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack. Clin Neurol Neurosurg 2008 110 (8) 779-783
7. Truelsen T, Piechowski-Jówiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006 13 (6) 581-598
8. Carerj L. Leonardo Botallo, the foramen ovale and the ductus arteriosus. Minerva Med 1955 46 789-795
9. Cohnheim J. Thrombose und Embolie In: Cohnheim J Vorlesung über allgemeine Pathologie. Berlin, Germany Hirschwald 1877 134
10. Zahn F W. Ueber paradoxe Embolie und ihre Bedeutung für die Geschwulstmetastase. Virchows Arch 1889 115 71-80
11. Gleysteen J J., Silver D. Paradoxical arterial embolism: collective review. Am Surg 1970 36 (1) 47-54
12. Lynch J J., Schuchard G H., Gross C M., Wann L S. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol 1984 53 (10) 1478-1480
13. Chen W J., Kuan P, Lien W P., Lin F Y. Detection of patent foramen ovale by contrast transesophageal echocardiography. Chest 1992 101 (6) 1515-1520
14. Homma S, Sacco R L. Patent foramen ovale and stroke. Circulation 2005 112 (7) 1063-1072
15. Hagen P T., Scholz D G., Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984 59 (1) 17-20
16. Topaz O, Feigl A, Edwards J E. Aneurysm of the fossa ovalis in infants: a pathologic study. Pediatr Cardiol 1985 6 (2) 65-68
17. Topaz O, Edwards J E., Bojack-Mackey S, Titus J L. Aneurysm of fossa ovalis in adults: a pathologic study. Cardiovasc Pathol 2003 12 (4) 219-225
18. Silver M D., Dorsey J S. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978 102 (2) 62-65
19. Mügge A, Daniel W G., Angermann C et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995 91 (11) 2785-2792
20. Hanley P C., Tajik A J., Hynes J K. et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985 6 (6) 1370-1382
21. Katayama H, Mitamura H, Mitani K, Nakagawa S, Ui S, Kimura M. Incidence of atrial septal aneurysm: echocardiographic and pathologic analysis [in Japanese]. J Cardiol 1990 20 (2) 411-421
22. Agmon Y, Khandheria B K., Meissner I et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999 99 (15) 1942-1944
23. Meissner I, Khandheria B K., Heit J A. et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006 47 (2) 440-445
24. Pearson A C., Nagelhout D, Castello R, Gomez C R., Labovitz A J. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991 18 (5) 1223-1229
25. Fox E R., Picard M H., Chow C M., Levine R A., Schwamm L, Kerr A J. Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J 2003 145 (4) 730-736
26. Schuchlenz H W., Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004 17 (3) 231-233
27. Revel M P., Faivre J B., Letourneau T et al. Patent foramen ovale: detection with nongated multidetector CT. Radiology 2008 249 (1) 338-345
28. Nusser T, Höher M, Merkle N et al. Cardiac magnetic resonance imaging and transesophageal echocardiography in patients with transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2006 48 (2) 322-329
29. Dubourg O, Bourdarias J P., Farcot J C. et al. Contrast echocardiographic visualization of cough-induced right to left shunt through a patent foramen ovale. J Am Coll Cardiol 1984 4 (3) 587-594
30. Homma S, Sacco R L., Di Tullio M R., Sciacca R R., Mohr J P., PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002 105 (22) 2625-2631
31. Cheng T O. The proper conduct of Valsalva maneuver in the detection of patent foramen ovale. J Am Coll Cardiol 2005 45 (7) 1145-1146
32. Devuyst G, Piechowski-Józwiak B, Karapanayiotides T et al. Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke 2004 35 (4) 859-863
33. Siostrzonek P, Zangeneh M, Gössinger H et al. Comparison of transesophageal and transthoracic contrast echocardiography for detection of a patent foramen ovale. Am J Cardiol 1991 68 (11) 1247-1249
34. Di Tullio M, Sacco R L., Venketasubramanian N, Sherman D, Mohr J P., Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993 24 (7) 1020-1024 (Pubitemid 23201460)
35. Belkin R N., Pollack B D., Ruggiero M L., Alas L L., Tatini U. Comparison of transesophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Am Heart J 1994 128 (3) 520-525
36. Kühl H P., Hoffmann R, Merx M W. et al. Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial right to left shunt in patients with cerebral embolic events. J Am Coll Cardiol 1999 34 (6) 1823-1830
37. Daniëls C, Weytjens C, Cosyns B et al. Second harmonic transthoracic echocardiography: the new reference screening method for the detection of patent foramen ovale. Eur J Echocardiogr 2004 5 (6) 449-452
38. Pearson A C., Labovitz A J., Tatineni S, Gomez C R. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991 17 (1) 66-72
39. Hofmann T, Kasper W, Meinertz T, Geibel A, Just H. Echocardiographic evaluation of patients with clinically suspected arterial emboli. Lancet 1990 336 (8728) 1421-1424
40. Schuchlenz H W., Weihs W, Beitzke A, Stein J I., Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 2002 33 (1) 293-296
41. Mügge A, Daniel W G., Klöpper J W., Lichtlen P R. Visualization of patent foramen ovale by transesophageal color-coded Doppler echocardiography. Am J Cardiol 1988 62 (10 Pt 1) 837-838
42. Schuchlenz H W., Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000 109 (6) 456-462
43. Homma S, Di Tullio M R., Sacco R L., Mihalatos D, Li Mandri G, Mohr J P. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994 25 (3) 582-586
44. Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 1996 77 (14) 1202-1209
45. Hamann G F., Schätzer-Klotz D, Fröhlig G et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998 50 (5) 1423-1428
46. Daniel W G., Erbel R, Kasper W et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991 83 (3) 817-821
47. Hüttemann E, Schelenz C, Kara F, Chatzinikolaou K, Reinhart K. The use and safety of transoesophageal echocardiography in the general ICUa minireview. Acta Anaesthesiol Scand 2004 48 (7) 827-836
48. Zabalgoitia M, Gandhi D K., Evans J, Mehlman D J., McPherson D D., Talano J V. Transesophageal echocardiography in the awake elderly patient: its role in the clinical decision-making process. Am Heart J 1990 120 (5) 1147-1153
49. Stoddard M F., Longaker R A. The safety of transesophageal echocardiography in the elderly. Am Heart J 1993 125 (5 Pt 1) 1358-1362
50. Nedeltchev K, Mattle H P. Contrast-enhanced transcranial Doppler ultrasound for diagnosis of patent foramen ovale. Front Neurol Neurosci 2006 21 206-215
51. Belvís R, Leta R G., Martí-Fàbregas J et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging 2006 16 (2) 133-138
52. Devuyst G, Despland P A., Bogousslavsky J, Jeanrenaud X. Complementarity of contrast transcranial Doppler and contrast transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur Neurol 1997 38 (1) 21-25
53. Messé S R., Kasner S E. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation 2008 118 (19) 1999-2004
54. Di Tullio M R., Sacco R L., Sciacca R R., Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007 49 (7) 797-802
55. Tillett A, Hartley B, Simpson J. Paradoxical embolism causing fatal myocardial infarction in a newborn infant. Arch Dis Child Fetal Neonatal Ed 2001 85 F137-F138
56. Kessel-Schaefer A, Lefkovits M, Zellweger M J. et al. Migrating thrombus trapped in a patent foramen ovale. Circulation 2001 103 (14) 1928
57. Fraticelli A, Gambini C, Iannoni E, Paciaroni E. Impending paradoxical embolism through a patent foramen ovale in an octogenarian with pulmonary embolism: detection by transesophageal echocardiography and successful treatment by anticoagulation. Arch Gerontol Geriatr 1998 27 (1) 41-47
58. Cabanes L, Mas J L., Cohen A et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993 24 (12) 1865-1873
59. Di Tullio M, Sacco R L., Gopal A, Mohr J P., Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992 117 (6) 461-465
60. Hausmann D, Mügge A, Becht I, Daniel W G. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992 70 (6) 668-672
61. Job F P., Ringelstein E B., Grafen Y et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994 74 (4) 381-384
62. Jones E F., Calafiore P, Donnan G A., Tonkin A M. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994 74 (6) 596-599
63. Yeung M, Khan K A., Shuaib A. Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1996 61 (5) 445-449
64. Silverstein M D., Heit J A., Mohr D N., Petterson T M., OFallon W M., Melton L J. III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998 158 (6) 585-593
65. Stöllberger C, Slany J, Schuster I, Leitner H, Winkler W B., Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993 119 (6) 461-465
66. Belcaro G, Geroulakos G, Nicolaides A N., Myers K A., Winford M. Venous thromboembolism from air travel: the LONFLIT study. Angiology 2001 52 (6) 369-374 (Pubitemid 32565949)
67. Heckmann J G., Stadter M, Reulbach U, Duetsch M, Nixdorff U, Ringwald J. Increased frequency of cardioembolism and patent foramen ovale in patients with stroke and a positive travel history suggesting economy class stroke syndrome. Heart 2006 92 (9) 1265-1268
68. Meister S G., Grossman W, Dexter L, Dalen J E. Paradoxical embolism. Diagnosis during life. Am J Med 1972 53 (3) 292-298
69. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blümel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998 97 (19) 1946-1951
70. Ueda R, Yokouchi M, Andou H et al. Pulmonary artery systolic pressure is elevated in the elderly: relationships between echocardiographic and pathological findings. Intern Med 2004 43 (5) 374-378
71. Mas J L., Arquizan C, Lamy C et al, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001 345 (24) 1740-1746
72. Berthet K, Lavergne T, Cohen A et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000 31 (2) 398-403
73. Cianciulli T F., Chejtman D, Lipshitz S B., Saccheri M C., Dethinne S L., Prezioso H A. Atrial septal aneurysm and spontaneous echo contrast: an association with higher embolic risk? Eur J Echocardiogr 2006 7 (3) 243-246
74. Homma S, DiTullio M R., Sacco R L., Sciacca R R., Mohr J P., PICSS Investigators. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004 35 (9) 2145-2149
75. Messé S R., Silverman I E., Kizer J R. et al, Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004 62 (7) 1042-1050
76. Sacco R L., Adams R, Albers G et al, American Heart Association American Stroke Association Council on Stroke Council on Cardiovascular Radiology and Intervention American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006 37 (2) 577-617 (Pubitemid 43732031)
77. Wahl A, Meier B, Haxel B et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001 57 (7) 1330-1332 (Pubitemid 32947402)
78. Hung J, Landzberg M J., Jenkins K J. et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000 35 (5) 1311-1316
79. Martín F, Sánchez P L., Doherty E et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002 106 (9) 1121-1126
80. Braun M, Gliech V, Boscheri A et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004 25 (5) 424-430
81. Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004 44 (4) 750-758 (Pubitemid 39099567)
82. Schuchlenz H W., Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005 101 (1) 77-82
83. Khairy P, ODonnell C P., Landzberg M J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003 139 (9) 753-760
84. Wahl A, Krumsdorf U, Meier B et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005 45 (3) 377-380
85. Spies C, Khandelwal A, Timmemanns I, Kavinsky C J., Schräder R, Hijazi Z M. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. Catheter Cardiovasc Interv 2008 72 (7) 966-970
86. Kiblawi F M., Sommer R J., Levchuck S G. Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc Interv 2006 68 (1) 136-142, discussion 143144
87. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006 37 (3) 859-864
88. Saver J L. Cryptogenic stroke in patients with patent foramen ovale. Curr Atheroscler Rep 2007 9 (4) 319-325
89. Thaler D E., Saver J L. Cryptogenic stroke and patent foramen ovale. Curr Opin Cardiol 2008 23 (6) 537-544
90. Lethen H, Flachskampf F A., Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997 80 (8) 1066-1069
91. Cramer S C., Rordorf G, Maki J H. et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004 35 (1) 46-50
92. Primary and Secondary Prevention of Cerebral Ischemia. Joint guidelines issued by the German Neurological Society (Deutsche Gesellschaft für Neurologie; DGN) and the German Stroke Society (Deutsche Schlaganfallgesellschaft; DSG). Published in German, September 2005. Available at: http://www.dgn.org/
93. Wahl A, Praz F, Stinimann J et al. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. Swiss Med Wkly 2008 138 (39-40) 567-572